ZOFRAN 8 Milligram Film Coated Tablet Ireland - English - HPRA (Health Products Regulatory Authority)

zofran 8 milligram film coated tablet

novartis pharmaceuticals uk ltd - ondansetron hydrochloride - film coated tablet - 8 milligram - serotonin (5ht3) antagonists

ZOFRAN 4 mg/5 ml MG/5ml Syrup Ireland - English - HPRA (Health Products Regulatory Authority)

zofran 4 mg/5 ml mg/5ml syrup

novartis pharmaceuticals uk ltd - ondansetron hydrochloride dihydrate - syrup - 4 mg/5 ml mg/5ml - serotonin (5ht3) antagonists

ZOFRAN ondansetron (as hydrochloride dihydrate) 8 mg/4 mL injection sterile syringe Australia - English - Department of Health (Therapeutic Goods Administration)

zofran ondansetron (as hydrochloride dihydrate) 8 mg/4 ml injection sterile syringe

aspen pharmacare australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 10 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: water for injections; citric acid monohydrate; sodium chloride; sodium citrate dihydrate - for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. for the prevention and treatment of post-operative nausea and vomiting. indications as at 25 july 1994: . for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy; . for the prevention and treatment post-operative nausea and vomiting.

ZOFRAN ondansetron (as hydrochloride dihydrate) 4 mg/2 mL injection sterile syringe Australia - English - Department of Health (Therapeutic Goods Administration)

zofran ondansetron (as hydrochloride dihydrate) 4 mg/2 ml injection sterile syringe

aspen pharmacare australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 5 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium citrate dihydrate; citric acid monohydrate - for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. for the prevention and treatment of post-operative nausea and vomiting. indications as at 25 july 1994: . for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy; . for the prevention and treatment post-operative nausea and vomiting. indications as at 10th february 1997: the prevention and treatment of post-operative nausea and vomiting in paediatric patients aged 2-12 years.

Zofran 8mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zofran 8mg tablets

novartis pharmaceuticals uk ltd - ondansetron hydrochloride dihydrate - oral tablet - 8mg

Zofran 4mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zofran 4mg tablets

novartis pharmaceuticals uk ltd - ondansetron hydrochloride dihydrate - oral tablet - 4mg

Zofran 4mg/5ml syrup United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zofran 4mg/5ml syrup

novartis pharmaceuticals uk ltd - ondansetron hydrochloride - oral solution - 800microgram/1ml

Zofran 16mg suppositories United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zofran 16mg suppositories

novartis pharmaceuticals uk ltd - ondansetron - suppository - 16mg

Zofran 4mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zofran 4mg tablets

waymade healthcare plc - ondansetron hydrochloride dihydrate - oral tablet - 4mg

Zofran 4mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

zofran 4mg tablets

dowelhurst ltd - ondansetron hydrochloride dihydrate - oral tablet - 4mg